跳到正文
FDA 官方药品与生物制品信息·· 9 天前AI 评分40

FDA 第804条进口计划政策与授权:科罗拉多州获批、佛罗里达州授权延期

Section 804 Importation Program Policies and Authorizations

AI 导读

FDA 于2026年6月依据《联邦食品、药品和化妆品法》第804条授权科罗拉多州药品进口计划,此前已于2024年1月授权佛罗里达州计划,并发布多份佛州授权延期函。FDA 还发布多项政策与行动推进各州及印第安部落从加拿大进口特定处方药,包括2025年7月州进口计划强化措施及2022年5月最终规则问答与小型实体合规指南。

正文 · 原文

FDA has issued policies and taken actions to implement section 804 of the Federal Food, Drug and Cosmetic Act, which allows states and Indian tribes to import certain prescription drugs from Canada to significantly reduce the cost of these drugs without imposing additional risk to public health and safety.

Actions

FDA authorizations

FDA authorized Colorado’s drug importation program under section 804 of the FD&C Act in June 2026:

FDA authorized Florida’s drug importation program under section 804 of the FD&C Act in January 2024:

来源:FDA 官方药品与生物制品信息 · fda.gov